OpenScience.ink

2 weeks ago • International journal of pharmaceutics

Using a temperature-sensitive nanoparticle to deliver Semaglutide through the nose: development, testing, and biological evaluationIntranasal delivery of Semaglutide using a thermoresponsive PNPHO nanocarrier: formulation development, characterization and biological evaluation.

📖 Top 20% JournalArticle

2 weeks ago • European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Predicting human drug effects using combined early-stage data shown with a GLP-1 receptor activatorM4 drug discovery: Human drug predictions from integrated preclinical insights exemplified with a GLP-1R agonist.

📖 Top 30% JournalArticle

2 weeks ago • Clinical medicine insights. Case reports

Liraglutide may reverse tamoxifen-related weight gain and metabolism problems in a breast cancer survivorSuccessful Reversal of Tamoxifen-Associated Weight Gain and Metabolic Dysfunction with Liraglutide in a Breast Cancer Survivor: A Case Report.

Case Reports

3 weeks ago • Biochemical pharmacology

Challenges in Developing Drugs for Diabetic Kidney Disease: Problems with Testing Targets and Ways to Improve TrialsDrug failure in diabetic kidney disease: translational barriers, target validation and trial de-risking strategies.

Article

3 weeks ago • International journal of obesity (2005)

Semaglutide under the skin and its link to weight loss and inflammation in overweight adults without diabetesEffects of subcutaneous semaglutide on weight loss and inflammatory markers in adults with overweight or obesity without diabetes: a systematic review and meta-analysis.

🎖️ Top 10% JournalSystematic Review

3 weeks ago • Frontiers in endocrinology

Tirzepatide’s effects on weight gain and blood sugar control after stomach surgery in people with type 2 diabetes and obesityClinical efficacy of tirzepatide for weight regain and suboptimal glycemic control following laparoscopic sleeve gastrectomy: a case series of three patients with obesity-associated type 2 diabetes.

🎖️ Top 10% JournalCase Reports

3 weeks ago • Frontiers in nutrition

Nutrition therapy in obesity-related heart failure treated with incretin drugsMedical nutrition therapy in incretin-treated obesity-related heart failure with preserved ejection fraction.

📖 Top 20% JournalArticle

3 weeks ago • Frontiers in neuroscience

Neuroprotective effects of GLP-1 and GIP drugs in Alzheimer's and Parkinson's diseaseGLP-1 and GIP class drugs have neuroprotective properties in Alzheimer's and Parkinson's disease.

📖 Top 20% JournalArticle

3 weeks ago • Federal practitioner : for the health care professionals of the VA, DoD, and PHS

Increasing Doses of Semaglutide Under the Skin May Lower Insulin Use in Type 2 Diabetes PatientsEfficacy of Subcutaneous Semaglutide Dose Escalation in Reducing Insulin in Patients With Type 2 Diabetes.

Article

3 weeks ago • Therapeutics and clinical risk management

Safe Use and Surgery Risk Management of GLP-1 Medicines: A Pharmacist-Guided Approach for Personalized CareMedication Safety and Perioperative Risk Management of GLP-1 Receptor Agonists: A Pharmacist-Led Framework for Individualized Care.

📖 Top 30% JournalArticle

3 weeks ago • Frontiers in medicine

Research on GLP-1 receptor drugs across the stages from fatty liver disease to liver inflammation and liver cancerMapping GLP-1 receptor agonist research across the MASLD-MASH-HCC continuum: a bibliometric and translational analysis.

📖 Top 20% JournalSystematic Review

3 weeks ago • EClinicalMedicine

How drugs that activate GLP-1 receptors may help reduce binge eating in people with obesityThe effectiveness of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on binge eating in patients with obesity: a systematic review and meta-analysis.

🥈 Top 2% JournalArticle

3 weeks ago • Obesity surgery

Barriers to Getting Metabolic and Weight Loss Surgery in the United StatesWeighed Down by Paperwork: Identifying Barriers to Metabolic and Bariatric Surgery Evaluation in the United States.

📖 Top 20% JournalArticle

3 weeks ago • Diabetes therapy : research, treatment and education of diabetes and related disorders

How SGLT2 Inhibitors May Help Prevent Type 2 Diabetes: A Review of Current EvidenceThe Role of SGLT2 Inhibitors in the Prevention of Type 2 Diabetes: A Narrative Review of Current Evidence.

📖 Top 20% JournalArticle

3 weeks ago • Frontiers in endocrinology

Glucagon-like peptide-1 receptor drugs and Parkinson's disease risk in people with type 2 diabetes: a review and analysis of large patient dataGlucagon-like peptide-1 receptor agonists and the risk of Parkinson's disease in patients with type 2 diabetes: a systematic review and meta-analysis of large-scale real-world data.

🎖️ Top 10% JournalSystematic Review

3 weeks ago • Cureus

Weight Regain After Weight Loss Surgery: Medications That Affect Digestion Hormones and the Changing Role of Follow-Up SurgeryWeight Recurrence After Bariatric Surgery: Incretin-Based Therapies and the Evolving Role of Revisional Surgery.

Article

3 weeks ago • JAMA network open

Stopping Semaglutide Treatment for Weight LossDiscontinuation of Semaglutide Therapy for Obesity Management.

🥈 Top 2% JournalArticle

3 weeks ago • JAMA health forum

How Out-of-Pocket Costs Relate to Taking Semaglutide for Obesity in Adults with Private InsuranceOut-of-Pocket Costs and Adherence to Semaglutide for Obesity Among Commercially Insured Adults.

🥉 Top 5% JournalArticle

3 weeks ago • Cureus

Blood Pressure Control in U.S. Adults with High Blood Pressure, Compared by Use of GLP-1 Receptor MedicinesBlood Pressure Control Among U.S. Adults With Hypertension, Stratified by Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Use: Evidence From the National Health and Nutrition Examination Survey, 2017-2020.

Article

3 weeks ago • Frontiers in neurology

Exendin-4 as a treatment for brain injury caused by inflammation in unborn babiesExendin-4 as a multi-target therapy for Fetal Inflammatory Response Syndrome-induced brain injury.

📖 Top 20% JournalArticle

3 weeks ago • The American journal of managed care

Predicting When People Stop Using GLP-1 Medications Based on Pharmacy RecordsPredicting GLP-1 Discontinuation From Pharmacy Claims.

📖 Top 30% JournalArticle

3 weeks ago • Maturitas

Incretin-based treatments for obese women during and after menopause: expert recommendations from the Spanish Menopause SocietyIncretin-based therapies in peri- and postmenopausal women with obesity: an expert position statement from the Spanish Menopause Society.

📖 Top 20% JournalArticle

3 weeks ago • Pain

Glucagon-like peptide-1 treatment is linked to less nerve damage and pain in type 2 diabetesGlucagon-like peptide-1 receptor agonist treatment is associated with lower frequency of diabetic peripheral neuropathy and neuropathic pain in type 2 diabetes.

Article

3 weeks ago • Journal of neurosurgery. Spine

Use of GLP-1 drugs linked to lower rates of bone fusion problems and swallowing difficulties after neck spine surgery, with effects changing over timeGLP-1 agonist use and lower rates of pseudarthrosis and dysphagia following anterior cervical discectomy and fusion surgery, with time-dependent effects.

Article

3 weeks ago • Therapeutic advances in endocrinology and metabolism

GLP-1 receptor drugs linking metabolism and gut inflammation in type 2 diabetes and inflammatory bowel diseaseGLP-1 receptor agonists at the crossroads of metabolic and gut inflammation: Implications for people with type 2 diabetes and inflammatory bowel disease.

🎖️ Top 10% JournalEditorial

3 weeks ago • British journal of clinical pharmacology

New treatment options for fatty liver disease linked to metabolismNew therapeutic options for metabolic-associated steatotic liver disease.

📖 Top 20% JournalArticle

3 weeks ago • Pediatric dermatology

Skin Side Effects of GLP-1 Medicines in Children: New Age-Related Patterns and What Dermatologists Should KnowAre Pediatric GLP-1 Receptor Agonist Cutaneous Adverse Events Being Overlooked? Emerging Age-Specific Patterns and Their Implications for Dermatologists.

📖 Top 50% JournalArticle

3 weeks ago • ACS omega

Uneven Electric Charges Affect the Stability of GLP-1 Drug Clusters Under Different Salt, Chemical, pH, and Temperature ConditionsAnisotropic Electrostatics in the Instability of GLP‑1 Analog Micelles: Effects of Electrolytes, Denaturants, pH, and Temperature.

📖 Top 30% JournalArticle

3 weeks ago • Journal of gastroenterology

Semaglutide effects in Japanese people with fatty liver disease linked to metabolism: a subgroup analysis of the ESSENCE trialSemaglutide in Japanese participants with metabolic dysfunction-associated steatohepatitis: a subgroup analysis of the ESSENCE trial.

🥉 Top 5% JournalArticle

3 weeks ago • Medicina (Kaunas, Lithuania)

Anti-Obesity Drugs and Their Potential to Improve Obesity-Related Reproductive Problems in WomenTherapeutic Potential of Anti-Obesity Drugs in Obesity-Associated Female Reproductive Dysfunction: Translating Mechanistic Evidence into Personalized Clinical Strategies.

📖 Top 30% JournalArticle

← prevpage 10 of 14next →

Latest GLP-1 Therapies Research Papers